Samrat Pharma (530125)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹341.9 |
| Market Cap | ₹106.84 Cr |
| P/E Ratio | 0 |
| ROCE | 13.21% |
| ROE | -2.41% |
| Dividend Yield | 0.48% |
| Profit Growth | -116.55% |
| Debt/Equity | — |
| Sales Growth | -0.36% |
| 52-Week Range | ₹190 — ₹389 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹232.67 |
Samrat Pharma trades with ROCE of 13.21%, ROE of -2.41%, profit growth of -116.55%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer